Mark Stenhouse

Mark Stenhouse

Director/Miembro de la Junta en PHATHOM PHARMACEUTICALS, INC. .

Fortuna: 325 500 $ al 30/06/2026

59 años
Health Technology
Consumer Services

Perfil

Mark Stenhouse is currently an Independent Director at Phathom Pharmaceuticals, Inc. since 2020.
Formerly, Mr. Stenhouse was Chief Operating Officer at Prometheus Biosciences, Inc. from 2021 to 2023, General Manager-Screening at EXACT Sciences Corp.
from 2019 to 2021, Director at Prometheus Laboratories, Inc. from 2018 to 2020, Vice President-U.S.
Immunology at AbbVie, Inc. from 2016 to 2018, and Vice President-US Immunology at Abbott Laboratories from 2006 to 2010.
Mr. Stenhouse completed undergraduate education at the College of Charleston.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
19/05/2026 30.000 ( 0,04 % ) 325 500 $ 30/06/2026

Cargos activos de Mark Stenhouse

EmpresasCargoInicio
PHATHOM PHARMACEUTICALS, INC. Director/Miembro de la Junta 17/03/2020

Antiguos cargos conocidos de Mark Stenhouse.

EmpresasCargoFin
PROMETHEUS BIOSCIENCES, INC. Director de Operaciones 16/06/2023
EXACT SCIENCES CORPORATION Corporate Officer/Principal 01/01/2021
Director/Miembro de la Junta 01/10/2020
ABBVIE INC. Corporate Officer/Principal 01/03/2018
ABBOTT LABORATORIES Corporate Officer/Principal 01/03/2010
Ver el detalle de la experiencia de Mark Stenhouse.

Formación de Mark Stenhouse.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

60

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology